Items where Author is "Algammal, A. M."

Article

(2026) Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023. JAMA. pp. 673-698. ISSN 1538-3598 (Electronic) 0098-7484 (Print) 0098-7484 (Linking)

(2026) Global and regional progress towards reduced burden of oral conditions between 2019 and 2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Public Health. e630-e641. ISSN 24682667 (ISSN)

(2026) Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990-2023: a Global Burden of Disease Study. Nature Medicine. pp. 527-544. ISSN 1078-8956

(2026) Global, regional and national burden of ischemic heart disease attributable to suboptimal diet, 1990-2023: a Global Burden of Disease study. Nature Medicine. pp. 1454-1478. ISSN 1078-8956

(2026) Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study. Nature Medicine. p. 46. ISSN 1078-8956

(2025) Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021. The Lancet Public Health. e172-e188. ISSN 24682667 (ISSN)

(2025) Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019. Nature Communications. p. 36.

(2025) Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study. Nature Medicine. pp. 1809-1829. ISSN 1078-8956

(2025) Global, regional, and national age-sex-specific burden of diarrhoeal diseases, their risk factors, and aetiologies, 1990–2021, for 204 countries and territories: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Infectious Diseases. pp. 519-536. ISSN 14733099 (ISSN)

(2025) Global, regional, and national burden of epilepsy, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet Public Health. e203-e227. ISSN 24682667 (ISSN)

(2025) Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet. pp. 813-838. ISSN 0140-6736

(2025) Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. The Lancet. pp. 785-812. ISSN 01406736 (ISSN)

(2024) Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. pp. 2341-2370. ISSN 01406736 (ISSN)

(2024) Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology. pp. 344-381. ISSN 1474-4422

(2024) Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021. Lancet. pp. 1955-1988. ISSN 0140-6736

(2024) National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050. The Lancet. pp. 2278-2298. ISSN 01406736 (ISSN)

(2022) Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019. Lancet Infectious Diseases. pp. 1626-1647. ISSN 1473-3099

(2022) The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. pp. 563-591. ISSN 0140-6736